Compare DTM & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DTM | FMS |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Misc Health and Biotechnology Services |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 13.9B |
| IPO Year | N/A | 1996 |
| Metric | DTM | FMS |
|---|---|---|
| Price | $119.88 | $21.99 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 11 | 2 |
| Target Price | ★ $124.91 | $30.00 |
| AVG Volume (30 Days) | ★ 636.8K | 501.2K |
| Earning Date | 02-25-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.72% | 2.60% |
| EPS Growth | N/A | ★ 8.62 |
| EPS | ★ 3.96 | 2.86 |
| Revenue | $1,175,000,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $27.83 | $2.13 |
| Revenue Next Year | $8.45 | $2.95 |
| P/E Ratio | $30.42 | ★ $14.41 |
| Revenue Growth | ★ 20.39 | 2.10 |
| 52 Week Low | $83.30 | $21.02 |
| 52 Week High | $122.70 | $30.46 |
| Indicator | DTM | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 37.86 |
| Support Level | $116.82 | $21.02 |
| Resistance Level | $119.62 | $23.93 |
| Average True Range (ATR) | 2.47 | 0.40 |
| MACD | -0.26 | -0.19 |
| Stochastic Oscillator | 66.21 | 31.91 |
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.